The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

被引:0
|
作者
Nicole Stopa
Jocelyn E. Krebs
David Shechter
机构
[1] University of Alaska Anchorage,Department of Biological Sciences
[2] Albert Einstein College of Medicine of Yeshiva University,Department of Biochemistry
来源
关键词
Protein arginine methyltransferase; Histones; Spliceosome; Development; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Post-translational arginine methylation is responsible for regulation of many biological processes. The protein arginine methyltransferase 5 (PRMT5, also known as Hsl7, Jbp1, Skb1, Capsuleen, or Dart5) is the major enzyme responsible for mono- and symmetric dimethylation of arginine. An expanding literature demonstrates its critical biological function in a wide range of cellular processes. Histone and other protein methylation by PRMT5 regulate genome organization, transcription, stem cells, primordial germ cells, differentiation, the cell cycle, and spliceosome assembly. Metazoan PRMT5 is found in complex with the WD-repeat protein MEP50 (also known as Wdr77, androgen receptor coactivator p44, or Valois). PRMT5 also directly associates with a range of other protein factors, including pICln, Menin, CoPR5 and RioK1 that may alter its subcellular localization and protein substrate selection. Protein substrate and PRMT5–MEP50 post-translation modifications induce crosstalk to regulate PRMT5 activity. Crystal structures of C. elegans PRMT5 and human and frog PRMT5–MEP50 complexes provide substantial insight into the mechanisms of substrate recognition and procession to dimethylation. Enzymological studies of PRMT5 have uncovered compelling insights essential for future development of specific PRMT5 inhibitors. In addition, newly accumulating evidence implicates PRMT5 and MEP50 expression levels and their methyltransferase activity in cancer tumorigenesis, and, significantly, as markers of poor clinical outcome, marking them as potential oncogenes. Here, we review the substantial new literature on PRMT5 and its partners to highlight the significance of understanding this essential enzyme in health and disease.
引用
收藏
页码:2041 / 2059
页数:18
相关论文
共 50 条
  • [1] The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
    Stopa, Nicole
    Krebs, Jocelyn E.
    Shechter, David
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (11) : 2041 - 2059
  • [2] Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
    Rasheed, Shayaan
    Bouley, Renee A.
    Yoder, Ryan J.
    Petreaca, Ruben C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [3] Zebrafish prmt5 arginine methyltransferase is essential for germ cell development
    Zhu, Junji
    Zhang, Dawei
    Liu, Xing
    Yu, Guangqing
    Cai, Xiaolian
    Xu, Chenxi
    Rong, Fangjing
    Ouyang, Gang
    Wang, Jing
    Xiao, Wuhan
    DEVELOPMENT, 2019, 146 (20):
  • [4] Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors
    Lin, Hong
    Luengo, Juan, I
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1264 - 1269
  • [5] Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
    Palte, Rachel L.
    Schneider, Sebastian E.
    Altman, Michael D.
    Hayes, Robert P.
    Kawamura, Shuhei
    Lacey, Brian M.
    Mansueto, My Sam
    Reutershan, Michael
    Siliphaivanh, Phieng
    Sondey, Christopher
    Xu, Haiyan
    Xu, Zangwei
    Ye, Yingchun
    Machacek, Michelle R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (09): : 1688 - 1693
  • [6] Aberrant miRNA expression and protein arginine methyltransferase 5 (PRMT5) in cancer: A review
    Sif, Said
    Al Alawneh, Majdi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2025, 1872 (03):
  • [7] The arginine methyltransferase PRMT5 promotes mucosal defense in the intestine
    Hernandez, Juan E.
    Llorente, Cristina
    Ma, Shengyun
    Miyamoto, Kiana T.
    Sinha, Saptarshi
    Steele, Scarlet
    Xiao, Zihui
    Lai, Ching-Jung
    Zuniga, Elina, I
    Ghosh, Pradipta
    Schnabl, Bernd
    Huang, Wendy Jia Men
    LIFE SCIENCE ALLIANCE, 2023, 6 (11)
  • [8] MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
    Kryukov, Gregory V.
    Wilson, Frederick H.
    Ruth, Jason R.
    Paulk, Joshiawa
    Tsherniak, Aviad
    Marlow, Sara E.
    Vazquez, Francisca
    Weir, Barbara A.
    Fitzgerald, Mark E.
    Tanaka, Minoru
    Bielski, Craig M.
    Scott, Justin M.
    Dennis, Courtney
    Cowley, Glenn S.
    Boehm, Jesse S.
    Root, David E.
    Golub, Todd R.
    Clish, Clary B.
    Bradner, James E.
    Hahn, William C.
    Garraway, Levi A.
    SCIENCE, 2016, 351 (6278) : 1214 - 1218
  • [9] Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
    Zheng, Jiahong
    Li, Bang
    Wu, Yingqi
    Wu, Xiaoshuang
    Wang, Yuanxiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (13) : 8407 - 8427
  • [10] Negative regulation of transcription by the type II arginine methyltransferase PRMT5
    Fabbrizio, E
    El Messaoudi, S
    Polanowska, J
    Paul, C
    Cook, JR
    Lee, JH
    Nègre, V
    Rousset, M
    Pestka, S
    Le Cam, A
    Sardet, C
    EMBO REPORTS, 2002, 3 (07) : 641 - 645